REQUEST A DEMO
Total
USD $0.00
Search more companies

Unidad Especializada en Alergia y Enfermedad Respiratoria S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Unidad Especializada en Alergia y Enfermedad Respiratoria S.A.S. Profile Updated: May 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Unidad Especializada en Alergia y Enfermedad Respiratoria S.A.S. is a company based in Colombia, with its head office in Bucaramanga. It operates in the Ambulatory Health Care Services industry. The company was established on April 17, 2019. The total number of employees is currently 2 (2026). The latest financial highlights indicate a net sales revenue increase of 20.06% in 2025. Its total assets grew by 44.6% over the same period. The enterprise’s net profit margin decreased by 5.64% in 2025.

Headquarters
Cl 54 33 45 P 11 In 1104 Ed Centro Medico Clinica Bucaramanga
Bucaramanga; Santander;

Contact Details: Purchase the Unidad Especializada en Alergia y Enfermedad Respiratoria S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Unidad Especializada en Alergia y Enfermedad Respiratoria S.A.S. report to view the information.
Financial Auditors:
Purchase the Unidad Especializada en Alergia y Enfermedad Respiratoria S.A.S. report to view the information.
Incorporation Date:
April 17, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Unidad Especializada en Alergia y Enfermedad Respiratoria S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
20.06%
Total Operating Revenue
20.06%
Net Profit/Loss for the Period
-24.88%
Total Assets
44.6%
Total Equity
53.46%
Net Profit Margin
-5.64%
Return on Equity (ROE)
-22.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?